These medications, known as GLP-1 receptor agonists (GLP-1-RAs), offer promising therapeutic options for type 2 diabetes and obesity-related conditions, including cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD) (6)
Rev J Chem 6(1):4982 Veld AM, Moleman P, Boomsma F, Schalekamp M (1987) Congenital dopamine-beta-hydroxylase deficiency: a novel orthostatic syndrome
Grundy SM (2004) Cholesterol gallstones: a fellow traveler with metabolic syndrome
08 Treating histamine intolerance Change of diet For histamine intolerance, a change in diet to a more or less histamine-free diet is the be-all and end-all
Product Name: Jennie Moon Gluta Glow Lyco Blink
Tumor-selective catalytic nanomedicine by nanocatalyst delivery